MedPath

Efficacy of Virtual Reality Reminiscence Therapy in Nursing Home Residents With Alzheimer's Disease or Related Diseases

Not Applicable
Not yet recruiting
Conditions
Virtual Reality
Reminiscence Therapy
Nursing Home
Alzheimer's Disease or Related Diseases
Crossover Study
Registration Number
NCT06960915
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

This project provides the easiest possible access to heritage elements that older persons with Alzheimer's disease or related diseases knew well but to which they no longer have access due to the motor and functional dependencies they present. It will strengthen the possibilities of reminiscence by using, rather than the usual supports, virtual reality technology to reinforce the immersion effect. It will involve carrying out virtual reality reminiscence workshops intended for residents in nursing home with Alzheimer's disease or related diseases and allowing them to explore the heritage of towns and villages in the Somme region thanks to these innovative solutions. The aim of this project is to reduce behavioral disorders and improve their quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Residents of the long-term care facilities of the Amiens-Picardie University Hospital,
  • Residents with mild to moderate Alzheimer's disease or related diseases, i.e. with an MMSE ≥ 10,
  • Residents or their legal representative agreeing to participate in the study.
Exclusion Criteria
  • Non-residents of the long-term care facilities of the Amiens-Picardie University Hospital,
  • Residents with an MMS < 10,
  • Residents or their legal representative refusing to participate in the study,
  • Residents in terminal palliative care,
  • Residents with disruptive behavioral disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Reduced behavioral problem frequency in immersive virtual reality group1 year

Efficacy in reducing behavioral problems will be assessed using the sum of scores on the NPI-ES anxiety, depression, and apathy subscales.

Secondary Outcome Measures
NameTimeMethod
Improved quality of life in the immersive virtual reality group1 year

improving the quality of life will be assessed using a quality of life scale developed for patients with Alzheimer's disease or related diseases, the QOL-AD scale validated in French.

The QOL-AD is administered in interview format to individuals with dementia, following the instructions below.

Scoring instructions for QOL-AD:

Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.

The total score is the sum of all 13 items.

Trial Locations

Locations (1)

CHRU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath